Invention Grant
- Patent Title: Pharmaceutical compositions comprising a ryanodine receptor modulator and uses thereof
-
Application No.: US17748886Application Date: 2022-05-19
-
Publication No.: US11717526B2Publication Date: 2023-08-08
- Inventor: Eugene E. Marcantonio , Mette Uhre Anby , Jérôme Binet
- Applicant: ARMGO Pharma, Inc.
- Applicant Address: US NY Ardsley
- Assignee: ARMGO Pharma, Inc.
- Current Assignee: ARMGO Pharma, Inc.
- Current Assignee Address: US NY Ardsley
- Agency: Wilson Sonsini Goodrich & Rosati
- Main IPC: A61K31/554
- IPC: A61K31/554 ; A61P21/00 ; A61K9/28
Abstract:
The present disclosure provides a modified-release pharmaceutical composition comprising 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyl]benzoic acid hemifumarate, and a pharmaceutically-acceptable excipient. The present disclosure methods of treating conditions associated with RyRs, including, for example, cardiac disorder or disease, a musculoskeletal disorder or disease, cancer associated muscle weakness, malignant hyperthermia, and diabetes.
Public/Granted literature
- US20220387442A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A RYANODINE RECEPTOR MODULATOR AND USES THEREOF Public/Granted day:2022-12-08
Information query
